Overview
Twogee Biotech is a Munich-based biotechnology startup founded in 2024 that specializes in enzymatic conversion of agricultural waste into valuable materials. The company’s proprietary enzyme platform efficiently breaks down lignocellulosic biomass (agricultural residues, forestry waste) into pure cellulose and second-generation sugars that serve as feedstock for bioplastics, biofuels, and other bio-based products.
Core Technology
Twogee Biotech’s enzymatic platform uses optimized enzyme cocktails to selectively degrade complex agricultural waste streams. Unlike traditional chemical processing, the enzymatic approach operates under mild conditions with lower energy input and reduced chemical waste. The primary outputs include:
- Pure cellulose: Suitable for textile, paper, and bioplastic applications
- 2G sugars: Fermentable sugars for bio-based chemical production
- Lignin fractions: Potential applications in bio-based materials and energy
Business Model
Twogee Biotech operates as a technology provider and processor, offering enzymatic conversion services to agricultural cooperatives, food processors, and bioplastic manufacturers. The company’s strain platform solution differentiates it in the competitive bioeconomy landscape by offering customized enzyme formulations for specific feedstock types.
Key Facts
- Founded: 2024
- Headquarters: Am Klopferspitz 19a, 82152 Martinsried, Germany
- Funding: $2.51M raised from 5 investors (including HTGF)
- Focus: Enzymatic biomass conversion and waste valorization
- Location: Martinsried biotech cluster, Munich
Strategic Relevance
Twogee Biotech’s technology directly supports the bioplastics supply chain by providing sustainable, second-generation sugar feedstocks that do not compete with food production. The enzymatic conversion of agricultural waste into fermentable sugars enables bio-based polymer production (PLA, PHA, bio-PE) from non-food biomass.
Last updated: June 28, 2026 Information sourced by HTGF, PitchBook, Tracxn, and Startbase